Chuck Sholtz is Vice President, Intellectual Property at Coherus Biosciences, a biosimilar platform company. His responsibilities include IP support for several Coherus pipeline products, including patent landscape analyses and IP strategy. Prior to joining Coherus, Chuck served for eight years as Senior Counsel in the IP Law Group at Amgen, where he supported programs in both the innovator and biosimilar sides of the company. Before earning his law degree at Santa Clara University, he worked as a post-doctoral fellow in the Neurology Department at Massachusetts General Hospital and the Department of Genetics at Harvard Medical School. Chuck has Bachelor of Science degrees in Cellular and Molecular Biology and Engineering Science (Bioengineering) from the University of Michigan, a Masters in Physiology from Yale, and a Ph.D. in Neuroscience from Stanford.